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Abstract
Objective: To assess the relationship between cognition and brain white matter (WM) lesion distribution and frequency in
patients with relapsing-remitting multiple sclerosis (RR MS).
Methods: MRI-based T2 lesion probability map (LPM) was used to assess the relevance of brain lesion location for cognitive
impairment in a group of 142 consecutive patients with RRMS. Significance of voxelwise analyses was p,0.05, cluster-
corrected for multiple comparisons. The Rao Brief Repeatable Battery was administered at the time of brain MRI to
categorize the MS population into cognitively preserved (CP) and cognitively impaired (CI).
Results: Out of 142 RRMS, 106 were classified as CP and 36 as CI. Although the CI group had greater WM lesion volume than
the CP group (p = 0.001), T2 lesions tended to be less widespread across the WM. The peak of lesion frequency was almost
twice higher in CI (61% in the forceps major) than in CP patients (37% in the posterior corona radiata). The voxelwise
analysis confirmed that lesion frequency was higher in CI than in CP patients with significant bilateral clusters in the forceps
major and in the splenium of the corpus callosum (p,0.05, corrected). Low scores of the Symbol Digit Modalities Test
correlated with higher lesion frequency in these WM regions.
Conclusions: Overall these results suggest that in MS patients, areas relevant for cognition lie mostly in the commissural
fiber tracts. This supports the notion of a functional (multiple) disconnection between grey matter structures, secondary to
damage located in specific WM areas, as one of the most important mechanisms leading to cognitive impairment in MS.
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Introduction
Cognitive impairment occurs in a significant proportion of
patients with multiple sclerosis (MS) [1,2]. It tends to worsen with
time, but might be relevant even at the earliest disease stages and is
primarily characterized by reduced information processing speed,
visual learning, working memory, long-term memory and execu-
tive functioning [1–3]. Given the high occurrence of cognitive
impairment in MS and its impact on the patients’ daily life, an
accurate definition and understanding of the mechanisms under-
lying its development is essential.
Since magnetic resonance imaging (MRI) is the most sensitive
tool to investigate in vivo tissue damage occurring in the MS brains,
many recent studies have used quantitative MRI-based techniques
to improve the knowledge of the substrates underlying cognitive
impairment in MS [4]. Indeed, several studies have shown that
greater lesion burden and brain atrophy occur in MS patients with
a more severe cognitive impairment [5–15]. In particular, the
pathologic substrate of cognitive impairment seems to be closely
related with grey matter (GM) damage such as cortical atrophy
[11,13,16] and cortical lesions [17,18], while this relationship is
less certain with macroscopic white matter (WM) damage. In such
a context, however, few recent studies have supported the early
notion that fiber disconnection, caused by both macroscopic and
microscopic WM damage, may represent one of the main factors
contributing to the development of cognitive impairment in MS
[19–21].
Among different MRI-derived approaches, lesion mapping has
shown to be a very powerful tool for studying distribution and
probability of occurrence of brain lesions [22–35], thus providing
clinically relevant information. In MS patients with cognitive
impairment, this should allow the visualization of spatial patterns
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of focal pathology that would appear much less evident in single
patient studies, potentially providing precious information on
domain-specific disconnection phenomena due to WM lesions.
Thus, with the aim to ascertain the relevance for cognition of WM
lesion spatial distribution and frequency, we created lesion
probability maps (LPMs) in two groups of relapsing remitting
(RR) MS patients with and without cognitive impairment.
Methods
Ethics statement
Informed written consent was obtained from all subjects and the
study was approved from the ethics committees of the University
of Siena and University of Florence.
Patient population
We studied 142 patients (107/35 women/men; age: mean 39.4
years, range 18.5–57.5 years) with clinically definite MS and RR
course according with the revised McDonald criteria [36]. Patients
were recruited among those who were consecutively referring to
the MS Clinics of the Universities of Siena and Florence during
the study period. All the patients were relapse-free and were not
taking steroids for at least one month prior to the assessment. No
subject was taking psychoactive drugs or substances that might
interfere with neuropsychological performance. Seventy-eight out
of 142 patients were on treatment (74 with immunomodulatory
and four with immunosuppressive drugs). All the patients
underwent a neurological evaluation, which included assessment
of the Expanded Disability Status Scale (EDSS) [37], neuropsy-
chological evaluation and conventional MRI scans within one-
week interval.
Neuropsychological assessment
In each center, neuropsychological testing was performed by a
well-trained psychologist who had participated in a common
training session and was blinded to the MRI results. Cognitive
functioning was measured through the Rao Brief Repeatable
Battery (BRB) of Neuropsychological Tests [38], which incorpo-
rates tests of verbal memory acquisition and delayed recall
(Selective Reminding Test – SRT), visual memory acquisition
and delayed recall (10/36 Spatial Recall Test – SPART),
attention, concentration and speed of information processing
(Paced Auditory Serial Addition Test – PASAT; Symbol Digit
Modalities Test – SDMT) and verbal fluency on semantic stimulus
(Word List Generation -WLG). Neuropsychological performance
was assessed using the normative data for the Italian population
[39]. In particular, failure of a test was defined as a score at least 2
SDs below the mean normative values. Patients with significant
cognitive impairment were defined as those showing the failure on
at least two tests of the BRB.
MR examination
All patients were examined using an identical MR protocol.
Acquisitions of brain MRIs were obtained in a single session using
a Philips Gyroscan at 1.5 T (Philips Medical Systems, Best, The
Netherlands). A sagittal survey image was used to identify the
anterior and posterior commissures (AC and PC). A dual-echo,
turbo spin-echo sequence (TR/TE1/TE2 = 2075/30/90 ms,
2566256 matrix, 1 signal average, 250 mm field of view [FOV],
50 contiguous 3 mm slices) yielding proton density (PD) and T2-
weighted (T2-W) images was acquired in the axial plane parallel to
the AC-PC line. Subsequently, axial T1-weighted (T1-W) gradient
echo images (TR/TE=35/10 milliseconds, 2566256 matrix, 1
signal average, 2506250 mm field-of-view) were acquired. This
sequence yielded image volumes of 50 slices, 3-mm thick, oriented
to match exactly the PD/T2 acquisition.
Periodical quality assurance sessions and no major hardware
upgrades were carried out on the scanner during the time of the
study.
Lesion volume
For each RRMS patient, MRI scan was first visually assessed by
a single observer, unaware of subject identity, and then labeling of
T2 lesions was performed by employing a semiautomated
segmentation technique based on user supervised local threshold-
ing (Jim 5.0, Xinapse System, Leicester, UK). For the T2-lesion
classification, lesion borders were determined primarily on PD
images but information from T2-W images was also considered.
The values of total brain T2-lesion volume (LV) was calculated by
multiplying lesion area by slice thickness.
Lesion probability maps
For each MS group, LPMs were obtained by using imaging
analysis tools of the FMRIB Software Library (FSL (www.fmrib.
ox.ac.uk/fsl/) [40] as described here:
1. The brain was extracted from the T1-W and PD images using
BET and then corrected for intensity nonuniformity [41]. The
same number of T1-W images of both cognitively impaired
(CI) and cognitively preserved (CP) patients were randomly
chosen from the total population and linearly registered to the
MNI152 standard brain by using FLIRT. Then, by averaging
the registered images, a symmetric study-specific template was
obtained [27].
2. A two-stage registration was carried out to align the T2-lesion
mask of each patient to the template. First, each lesion mask
was linearly registered on the T1-W image using the
transformation parameters derived by linearly registering the
PD on the T1-W image. Second, each lesion mask previously
registered on the T1-W image was nonlinearly registered on
the template with FNIRT using the transformation parameters
derived by nonlinearly registering the T1-W image on the
template. The nearest neighbor interpolation method was used
in both stages. Quality checks were done at all steps by two
independent observers (F.R. and M.B.), who found the
registration to be satisfactory in all cases.
3. Finally, for each patient group, LPM was generated by first
merging and then averaging all the standard-space lesion
masks. For each map, voxel intensity represents the frequency
of lesion occurrence in that voxel or, in other words, the
probability of that voxel being lesion for the patient group.
4. As the last step, we computed a measure of the consistency of
lesion pattern across patients of each group. This was described
as LPM index (LPMi) in a previous work [22] and was
obtained by performing the equation
LPMi~100 x ½m (Mi|LPMG),
in which Mi is the binarized, segmented lesion mask of the patient,
LPMG is the LPM of the corresponding patient group and m is the
resulting mean. As a result of this procedure, LPMi is higher when
the patient’s lesion mask is localized in brain regions with a high
probability of being lesion for that group.
T2 Lesion Location and Cognition in MS
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General statistics
Nonparametric Mann-Whitney test was used for between-group
comparisons of demographic (age), clinical (EDSS, disease
duration) and MRI (T2-LV and LPMi) features. To account for
differences in head size, for each patient LV was measured in
common standard space, and this was used in all subsequent
analyses. The Fisher’s exact test was used to compare sex between
the two groups of CI and CP patients. Data were considered
significant at p,0.05.
Voxelwise statistics
Voxelwise statistical inference on LPM was done in the General
Linear Model (GLM) framework with randomise, an FSL program,
which performs nonparametric permutation testing (5000 permu-
tations) [42]. To compare probability of lesion occurrence between
the two patient groups (CP and CI) a voxelwise unpaired t-test was
used. To correlate probability of lesion occurrence with the scores
of the different tests of BRB across the whole patient population
voxelwise regression analyses were used. In all analyses, age and
sex were used as covariates. In addition, since it is not clear
whether the total brain LV can be relevant to lesion frequency
assessment [23,25,26], all analyses were repeated adding T2-LV as
a covariate. Values of T2-LV were log-transformed in order to
obtain a normal distribution. Further, an analysis on three groups
was performed to assess the relevance of the number of failed tests.
At F-contrast testing among these three groups, the main effect of
group (i.e., showing the brain regions with significant heteroge-
neity) was created and used to mask all subsequent pairwise
comparisons.
Thresholding was carried out using TFCE (Threshold-Free
Cluster Enhancement), a method for finding significant clusters in
MRI data without having to define them in a binary way [43].
Clusters were considered significant at p,0.05, fully corrected for
multiple comparisons across space. Within clusters showing
significant correlation of lesion frequency with BRB test scores,
we extracted for each patient the mean signal intensity value (i.e.,
the percentage of lesion voxel) across the voxels within the
significant cluster and correlated this with BRB test score in order
to assess the Spearman correlation coefficient between the two
parameters.
Anatomical location of the significant clusters was determined
by using the Johns Hopkins University Diffusion Tensor Imaging-
based atlases of WM anatomy provided by FSL.
Results
Demographic and clinical characteristics
Demographic, clinical and MRI data of our population are
summarized in Table 1. The BRB identified 36 CI patients, while
106 patients were CP. Number of patients failing each test of the
BRB is shown in Table 2. CI patients were older than CP patients
(p = 0.008) and tended to be more disabled (p= 0.06), but no
differences were found in disease duration (p = 0.7). T2-LV was
significantly higher in CI than in CP patients (p = 0.001).
LPM Analyses
Comparison between CP and CI groups. The overall
anatomical distribution of T2 lesions across the brain was similar
in CP and CI patients (Figure 1). However, in the CI group T2
lesions tended to have a less widespread distribution despite their
greater volume. The peak of lesion frequency was almost twice
higher in CI (61% in the forceps major [FM]) than in CP patients
(37% in the posterior corona radiata). Moreover the LPMi, which
is a measure of the consistency of lesion pattern across subjects of a
group, was higher in CI than in CP patients (16.5%65.2% versus
9.4%63%, p,0.001).
The voxelwise analysis confirmed that lesion frequency was
higher in CI than in CP patients, with significant bilateral clusters
in the FM and in the splenium of the corpus callosum (sCC)
(p,0.05, corrected) (Figure 2, Table 3). After correcting also for
T2-LV differences, only bilateral clusters in the FM were retained
(p,0.05, corrected) (Figure 2).
Comparison among groups with different number of
failed tests. To assess the relevance of the increasing number of
failed tests on lesion location and frequency, a further analysis was
performed considering three groups of MS patients: those with no
test failed (n = 85 patients), those with one test failed (n = 21
patients) and patients with two or more tests failed (n = 36
patients). The FM, the sCC as well as the superior longitudinal
fascicle (SLF) on the left hemisphere were the WM regions where







Age, y, mean6SD 39.469.1 38.268.8 42.869.12
(range) (18.5–57.5) (18.5–57.5) (20.6–56.6)
Male/Female 35/107 26/80 9/27
EDSS, mean6SD 1.861.2 1.761.1 2.261.4
(range) (0–6) (0–5.5) (0–6)
Disease duration, y, 11.069.8 11.2610 10.669.1
mean6SD (range) (0.02–41.6) (0.02–41.6) (0.3–35.2)
T2-LV, cm3, mean6SD 13.1613.5 11.2612.6 18.8614.4
(range) (0.1–60.2) (0.1–60.2) (0.2–44.4)
CP = Cognitively Preserved.
CI = Cognitively Impaired.
See text for details.
doi:10.1371/journal.pone.0044826.t001
Table 2. Neuropsychological tests failed by cognitively
impaired MS patients.









SDMT = Symbol Digit Modalities Test.
PASAT = Paced Auditory Serial Addition Test.
SRT-LTS = Selective Reminding Test- Long Term Storage.
SRT-CLTR = Selective Reminding Test Consistent- Long Term Retrieval.
SPART = Spatial Recall Test.
SPART-DR = Spatial Recall Test- Delayed Recall.
WLG= Word List Generation.
SRT-DR = Selective Reminding Test -Delayed Recall.
doi:10.1371/journal.pone.0044826.t002
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the lesion frequency showed to be different among the three
groups (p,0.05, corrected). In particular, patients with a high
number of failed tests had higher lesion frequency in the FM and
SLF (p,0.05, corrected) than patients who never failed at the
BRB tests. After correcting also for T2-LV differences, a
significant cluster was retained only in the FM. Patients with a
high number of failed tests showed higher lesion frequency in the
left sCC (p,0.05, corrected) than patients who failed one test at
the BRB. This region survived correction also for T2-LV
differences. By contrast, no significant differences in lesion
frequency were found between patients who never failed and
patients who failed one test at the BRB.
Correlation between BRB scores and lesion
frequency. In general, the score of the different neuropsycho-
logical tests did not correlate with higher lesion frequency in
specific brain regions, with the exception of the SDMT, where
lower scores correlated with higher lesion frequency in the
bilateral FM, sCC, left forceps minor (Fmin) and inferior fronto-
occipital fascicle (IFOF) (p,0.05, corrected) (Table 4). In all these
clusters, correlation between mean lesion signal intensity (i.e., the
percentage of lesion voxels in each patient) and SDMT score was
r = -0.50, p,0.001. After correcting also for T2-LV, smaller
clusters in the bilateral FM, sCC and left Fmin were retained
(p,0.05, corrected). The mean signal intensity value within these
clusters inversely correlated with SDMT scores (r =20.55,
p,0.001).
Discussion
Given the very high detrimental impact of cognitive impairment
on the daily life activities of a large proportion of MS patients, it is
very important to know the mechanisms that can potentially
contribute to its development and progression. In particular, it is
still unclear from previous studies [23,24,30,34,35] whether there
are significant differences in brain lesion location between CI and
CP patients with MS, and consequently the relevance for cognitive
impairment of the presence of a great lesion load in specific sites of
the cerebral WM.
Figure 1. LPM in cognitively impaired and cognitively preserved patients with MS. T2-weighted lesion probability maps in cognitively
impaired (upper panel, n = 36) and cognitively preserved (lower panel, n = 106) patients with MS. The color overlay created on top of the Montreal
Neurological Institute standard brain shows the probability of each voxel containing a lesion in each patient group. The color bar denotes the
probability range. The maximum local probability for lesions was higher in cognitively impaired patients (61% peak probability in the forceps major)
than in cognitively preserved patients (37% peak probability in the posterior corona radiata). Images are shown in radiological convention.
doi:10.1371/journal.pone.0044826.g001
Figure 2. Clusters of high lesion frequency in cognitively
impaired MS patients. Yellow shows the clusters of voxels where
lesions, after controlling for age and sex, were more frequent (p,0.05,
corrected) in cognitively impaired (n = 36) than in cognitively preserved
(n = 106) patients with MS (forceps major in A and splenium of the
corpus callosum in B). Red shows the clusters of voxels that also
survived correction for T2-LV (forceps major, in A). Green represents the
WM fiber tract (forceps major, in A) obtained from the FSL probabilistic
tractography atlas. Background image is the MNI152 standard space
image. Images are shown in radiological convention.
doi:10.1371/journal.pone.0044826.g002
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To provide an answer to this important issue, we exploited the
potentials of the MRI-derived LPMs in assessing, at the voxel
level, differences across populations in brain lesion spatial
distribution and frequency and created LPMs of two groups of
RRMS patients with and without cognitive impairment. We found
that, despite CI patients had significantly greater LV than CP
patients, their lesion patterns were more consistent across the
brain, as also shown by their significantly higher LPMi. Indeed,
the area with the highest probability of being lesion in CI patients
was almost twice higher in CI than in CP, being localized to the
FM (61%). Moreover, at voxelwise analysis, clusters of lesions in
this area and in the sCC could distinguish CI patients from those
who were CP (Figure 2). Overall, these results suggest that i)
anatomic location of WM lesions is important in the development
and progression of cognitive impairment, and ii) areas relevant for
cognition lie mostly in the fibers crossing the CC.
Several MRI studies [4,44] have shown that patients with
greater lesion burden have significantly more cognitive impair-
ment than those with less lesion burden. Some studies have also
suggested that analysis of regional cerebral lesion load may help
understanding the pattern and course of cognitive impairment in
MS [23,24,30,34,35]. However, the overall relationship between
cognitive impairment and lesion load was found to be weak-to-
moderate and it is still unclear whether the presence of
demyelinating lesions in a particular brain region is more relevant
to cognitive impairment in MS. This has led to the notion that
cognitive impairment cannot be adequately explained by the
pathological features revealed by conventional MRI, which is
somehow limited to the detection of macroscopic brain damage
[4,44]. In this study, however, by creating MRI-derived LPMs for
each patient group, we showed that specific brain regions (i.e., FM
and other areas of the CC) were more frequently classified as
lesions in CI than in CP patients with MS, a finding that would
have not been noted on MR images from single patients. Given
the peculiar features of these regions, which are part of the
commissural tracts connecting cortical and subcortical regions of
both hemispheres, this result is particularly interesting. Indeed, this
supports the early notion of a functional (multiple) disconnection
between different GM structures, secondary to WM damage, as
responsible for cognitive impairment in MS. Recent nonconven-
tional MRI studies, by using diffusion tensor imaging (DTI)
[20,21,45,46], show a selective microstructural (i.e., non-lesional)
damage in these regions of the CC and thus further support the
hypothesis that a disconnection of these brain areas may play a
role in the pathophysiology of cognitive impairment in MS.
Among the different cognitive tests, only the SDMT, which is a
very sensitive measure of information processing speed, attention
and working memory [47], showed a significant correlation with
WM lesions. More specifically, low SDMT scores were associated
with high lesion frequency in FM, Fmin, sCC and IFOF. The
correlation with FM and sCC survived after correction for T2-LV.
FM, which can be considered as the occipital radiation of the CC,
has been associated with important cognitive domains such as
attention, memory and executive functions [48,49]. Indeed, the
involvement of the FM in memory has been demonstrated by the
presence of a fiber tract traveling between the sCC and
Table 3. White matter regions of high lesion frequency in cognitively impaired MS patients.
WM region Side MNI (mm) t-statistics Cluster size p-value
(local maxima) X Y Z (voxel number)
Forceps major L 224 270 8 5.28 788 0.001
R 16 282 16 4.64 135 0.004
Splenium of
the corpus callosum
R 20 244 24 4.81 42 0.012
L 220 250 22 3.59 788 0.001
Local maxima within each significant cluster (p,0.05, corrected) where lesion frequency was higher in cognitively impaired than in cognitively preserved MS patients,
after correcting for age and sex. After correcting also for T2-LV differences, only bilateral clusters in the FM were retained (p,0.05, corrected). See text for abbreviations.
doi:10.1371/journal.pone.0044826.t003
Table 4. White matter regions of higher lesion frequency with lower SDMT scores.
WM region Side MNI (mm) t-statistics Cluster size p-value
(local maxima) X Y Z (voxel number)
Forceps major R 30 252 12 4.39 480 0.001
L 216 286 4 2.94 1220 0.001
Forceps minor L 216 30 2 4.38 46 0.005
Inferior fronto-occipital fascicle R 34 250 6 4.12 480 0.001
L 226 270 0 3.53 1220 0.001
Splenium of the corpus callosum R 18 250 24 3.56 480 0.001
L 218 252 22 3.24 1220 0.001
Local maxima within significant clusters (p,0.05, corrected) where lower SDMT scores correlated with higher T2 lesion frequency, after correcting for age and sex. After
correcting also for T2-LV, smaller clusters in the bilateral FM, sCC and left Fmin were retained and correlation between the percentage of lesion voxels in these clusters
and SDMT scores was r =20.55, p,0.001. See text for abbreviations.
doi:10.1371/journal.pone.0044826.t004
T2 Lesion Location and Cognition in MS
PLOS ONE | www.plosone.org 5 November 2012 | Volume 7 | Issue 11 | e44826
hippocampus which connects to the fornix and the FM [50].
Moreover, a significant correlation was found between WM
volume in the left FM and a factor of general cognition and mental
ability in healthy old subjects [49]. Other recent studies have used
LPM to assess correlations between a given cognitive test and
specific brain regions in MS patients [23,24,30,34,35]. One study
on CIS patients [24] showed that verbal learning performances
were inversely associated with lesions in Broca’s area, right frontal
lobe and sCC and that spatial learning performances were
inversely correlated with lesions in the deep WM, whereas it did
not find significant correlations between lesion location and
performance in tasks exploring processing speed and executive
functions. Another study [23], including patients with different MS
subtypes, found significant correlation of WLG with lesions in the
left SLF and, when data were not corrected for multiple
comparisons, could also show correlation of SDMT with lesions
in the left frontal lobe. Beside differences due to patient
populations or technical approaches, it is possible that measures
of information processing speed, attention and working memory
such as SDMT might be more sensitive to pronounced tissue
damage (i.e., high lesion load) as the one reported in our study
[51]. However, a very recent DTI study [52] showed very close
correlation between low SDMT scores and mostly non-lesional
brain regions such as CC, sagittal stratum and posterior thalamic
radiation (including optic radiation), suggesting that microstruc-
tural damage may exist in these regions even before macroscopic
lesions become evident. Finally, the close relationship of SDMT,
which is a measure of visual processing speed, with tissue damage
in regions containing fiber tracts connecting to the occipital cortex
(i.e., FM and optic radiation), as found in our LPM study and in a
previous DTI work [53], might provide a biological explanation of
the visual perceptual deficits occurring in MS patients with
cognitive impairment.
Voxel-based analyses such as those performed here have
strengths and limitations. A strength that should be considered is
the methodological approach used to create the LPMs. We used
here the nonlinear registration to align patients’ brain, which
diminishes the potential bias coming from errors in registration
and greatly improves the alignment upon visual inspection.
Moreover, we carried out analyses by using nonparametric
permutation tests, which are particularly useful when the study
groups are composed of unequal numbers of subjects [42], as the
data presented here. Finally, as most recent studies [23,31], we
applied for data analysis TFCE, which uses the spatial information
inherent in the data to calculate statistical maps, thus not requiring
arbitrary presmoothing of images and not depending on an
arbitrary initial cluster-forming threshold [43,52]. By contrast, a
limitation of the study lies in the selective use of WM T2 lesions,
without assessing, for example, differences in cortical LPM [28] or
cortical atrophy [11]. On a different perspective, another
limitation of our study might be represented by the fact that
fatigue and depression scales (such as FSS and MADRS) were not
acquired. However, we did not include in our study subjects with
major mood disorders or on treatment with psychoactive drugs.
Conclusions
It is well know that the cognitive impairment in MS has
complex and multifactorial causes, which cannot be adequately
and exclusively explained by pathological features captured by an
unspecific measurement such as T2 lesions. The results reported
here, however, support the notion that focal damage in specific
brain WM regions (i.e., commissural fibers) is particularly relevant
to cognition. This might contribute to improve the knowledge on
the pathophysiology of cognitive impairment in MS, potentially
leading to the development of better outcome measures and
targets for new treatment strategies in this disabling condition.
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